Biogen’s stock climbs as first-quarter profit tops estimates, Alzheimer’s drug uptake improves

Biogen shares gained ground before market open Wednesday, after the company reported first-quarter profit that beat analysts’ expectations amid improving uptake of its Alzheimer’s treatment.

Previous post Oil prices hold steady ahead of weekly U.S. crude stockpile data
Next post Hilton’s stock pops after earnings beat estimates, despite the impact of bad weather